 | • レポートコード：20QY06-07232 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、大うつ病性障害薬のグローバル市場について種類別（アリピプラゾール、AV-101、AVP-786、バシムグルラント、ブレクスピプラゾール、その他）、用途別（病院、クリニック、研究センター）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・大うつ病性障害薬市場の概要 ・世界の主要地域別大うつ病性障害薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の大うつ病性障害薬市場規模2015-2026：種類別（アリピプラゾール、AV-101、AVP-786、バシムグルラント、ブレクスピプラゾール、その他） ・世界の大うつ病性障害薬市場規模2015-2026：用途別（病院、クリニック、研究センター） ・大うつ病性障害薬の北米市場規模2015-2020 ・大うつ病性障害薬のヨーロッパ市場規模2015-2020 ・大うつ病性障害薬の中国市場規模2015-2020 ・大うつ病性障害薬の日本市場規模2015-2020 ・大うつ病性障害薬の東南アジア市場規模2015-2020 ・大うつ病性障害薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bristol-Myers Squibb Company、Cerecor Inc.、e-Therapeutics Plc、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline Plc、H. Lundbeck A/S、Hua Medicine Ltd.、Intra-Cellular Therapies, Inc.） ・大うつ病性障害薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・大うつ病性障害薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Major Depressive Disorder Drug Market
The global Major Depressive Disorder Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Major Depressive Disorder Drug Scope and Market Size
The global Major Depressive Disorder Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Major Depressive Disorder Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Major Depressive Disorder Drug market is segmented into
Aripiprazole
AV-101
AVP-786
Basimglurant
Brexpiprazole
Others
Segment by Application, the Major Depressive Disorder Drug market is segmented into
Hospital
Clinic
Research Center
The Major Depressive Disorder Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Major Depressive Disorder Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Major Depressive Disorder Drug Market Share Analysis
Major Depressive Disorder Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Major Depressive Disorder Drug business, the date to enter into the Major Depressive Disorder Drug market, Major Depressive Disorder Drug product introduction, recent developments, etc.
The major vendors covered:
Bristol-Myers Squibb Company
Cerecor Inc.
e-Therapeutics Plc
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
H. Lundbeck A/S
Hua Medicine Ltd.
Intra-Cellular Therapies, Inc.
Table of Contents
1 Major Depressive Disorder Drug Market Overview
1.1 Major Depressive Disorder Drug Product Scope
1.2 Major Depressive Disorder Drug Segment by Type
1.2.1 Global Major Depressive Disorder Drug Sales by Type (2020-2026)
1.2.2 Aripiprazole
1.2.3 AV-101
1.2.4 AVP-786
1.2.5 Basimglurant
1.2.6 Brexpiprazole
1.2.7 Others
1.3 Major Depressive Disorder Drug Segment by Application
1.3.1 Global Major Depressive Disorder Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Major Depressive Disorder Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Major Depressive Disorder Drug Sales Growth Rate (2015-2026)
1.4.2 Global Major Depressive Disorder Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Major Depressive Disorder Drug Price Trends (2015-2026)
2 Major Depressive Disorder Drug Estimate and Forecast by Region
2.1 Global Major Depressive Disorder Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Major Depressive Disorder Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Major Depressive Disorder Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Major Depressive Disorder Drug Revenue Market Share by Region (2015-2020)
2.3 Global Major Depressive Disorder Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Major Depressive Disorder Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Major Depressive Disorder Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Major Depressive Disorder Drug Estimates and Projections (2015-2026)
2.4.2 Europe Major Depressive Disorder Drug Estimates and Projections (2015-2026)
2.4.3 China Major Depressive Disorder Drug Estimates and Projections (2015-2026)
2.4.4 Japan Major Depressive Disorder Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Major Depressive Disorder Drug Estimates and Projections (2015-2026)
2.4.6 India Major Depressive Disorder Drug Estimates and Projections (2015-2026)
3 Global Major Depressive Disorder Drug Competition Landscape by Players
3.1 Global Top Major Depressive Disorder Drug Players by Sales (2015-2020)
3.2 Global Top Major Depressive Disorder Drug Players by Revenue (2015-2020)
3.3 Global Major Depressive Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Major Depressive Disorder Drug as of 2019)
3.4 Global Major Depressive Disorder Drug Average Price by Company (2015-2020)
3.5 Manufacturers Major Depressive Disorder Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Major Depressive Disorder Drug Players (Opinion Leaders)
4 Global Major Depressive Disorder Drug Market Size by Type
4.1 Global Major Depressive Disorder Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Major Depressive Disorder Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Major Depressive Disorder Drug Price by Type (2014-2020)
4.2 Global Major Depressive Disorder Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Major Depressive Disorder Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Major Depressive Disorder Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Major Depressive Disorder Drug Price Forecast by Type (2021-2026)
5 Global Major Depressive Disorder Drug Market Size by Application
5.1 Global Major Depressive Disorder Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Major Depressive Disorder Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Major Depressive Disorder Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Major Depressive Disorder Drug Price by Application (2015-2020)
5.2 Global Major Depressive Disorder Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Major Depressive Disorder Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Major Depressive Disorder Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Major Depressive Disorder Drug Price Forecast by Application (2021-2026)
3 North America Major Depressive Disorder Drug Market Facts & Figures
3.2 North America Major Depressive Disorder Drug Sales Market Share by Company (2015-2020)
3.3 North America Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
3.4 North America Major Depressive Disorder Drug Sales Market Share by Application (2015-2020)
4 Europe Major Depressive Disorder Drug Market Facts & Figures
4.2 Europe Major Depressive Disorder Drug Sales Market Share by Company (2015-2020)
4.3 Europe Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
4.4 Europe Major Depressive Disorder Drug Sales Market Share by Application (2015-2020)
5 China Major Depressive Disorder Drug Market Facts & Figures
5.2 China Major Depressive Disorder Drug Sales Market Share by Company (2015-2020)
5.3 China Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
5.4 China Major Depressive Disorder Drug Sales Market Share by Application (2015-2020)
6 Japan Major Depressive Disorder Drug Market Facts & Figures
6.2 Japan Major Depressive Disorder Drug Sales Market Share by Company (2015-2020)
6.3 Japan Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
6.4 Japan Major Depressive Disorder Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Major Depressive Disorder Drug Market Facts & Figures
7.2 Southeast Asia Major Depressive Disorder Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Major Depressive Disorder Drug Sales Market Share by Application (2015-2020)
8 India Major Depressive Disorder Drug Market Facts & Figures
8.2 India Major Depressive Disorder Drug Sales Market Share by Company (2015-2020)
8.3 India Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
8.4 India Major Depressive Disorder Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Major Depressive Disorder Drug Business
12.1 Bristol-Myers Squibb Company
12.1.1 Bristol-Myers Squibb Company Major Depressive Disorder Drug Corporation Information
12.1.2 Bristol-Myers Squibb Company Major Depressive Disorder Drug Business Overview and Total Revenue
12.1.3 Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bristol-Myers Squibb Company Major Depressive Disorder Drug Products Offered
12.1.5 Bristol-Myers Squibb Company Recent Development
12.2 Cerecor Inc.
12.2.1 Cerecor Inc. Major Depressive Disorder Drug Corporation Information
12.2.2 Cerecor Inc. Major Depressive Disorder Drug Business Overview and Total Revenue
12.2.3 Cerecor Inc. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Cerecor Inc. Major Depressive Disorder Drug Products Offered
12.2.5 Cerecor Inc. Recent Development
12.3 e-Therapeutics Plc
12.3.1 e-Therapeutics Plc Major Depressive Disorder Drug Corporation Information
12.3.2 e-Therapeutics Plc Major Depressive Disorder Drug Business Overview and Total Revenue
12.3.3 e-Therapeutics Plc Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 e-Therapeutics Plc Major Depressive Disorder Drug Products Offered
12.3.5 e-Therapeutics Plc Recent Development
12.4 Eli Lilly and Company
12.4.1 Eli Lilly and Company Major Depressive Disorder Drug Corporation Information
12.4.2 Eli Lilly and Company Major Depressive Disorder Drug Business Overview and Total Revenue
12.4.3 Eli Lilly and Company Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eli Lilly and Company Major Depressive Disorder Drug Products Offered
12.4.5 Eli Lilly and Company Recent Development
12.5 F. Hoffmann-La Roche Ltd.
12.5.1 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Corporation Information
12.5.2 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Business Overview and Total Revenue
12.5.3 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Products Offered
12.5.5 F. Hoffmann-La Roche Ltd. Recent Development
12.6 GlaxoSmithKline Plc
12.6.1 GlaxoSmithKline Plc Major Depressive Disorder Drug Corporation Information
12.6.2 GlaxoSmithKline Plc Major Depressive Disorder Drug Business Overview and Total Revenue
12.6.3 GlaxoSmithKline Plc Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 GlaxoSmithKline Plc Major Depressive Disorder Drug Products Offered
12.6.5 GlaxoSmithKline Plc Recent Development
12.7 H. Lundbeck A/S
12.7.1 H. Lundbeck A/S Major Depressive Disorder Drug Corporation Information
12.7.2 H. Lundbeck A/S Major Depressive Disorder Drug Business Overview and Total Revenue
12.7.3 H. Lundbeck A/S Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 H. Lundbeck A/S Major Depressive Disorder Drug Products Offered
12.7.5 H. Lundbeck A/S Recent Development
12.8 Hua Medicine Ltd.
12.8.1 Hua Medicine Ltd. Major Depressive Disorder Drug Corporation Information
12.8.2 Hua Medicine Ltd. Major Depressive Disorder Drug Business Overview and Total Revenue
12.8.3 Hua Medicine Ltd. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Hua Medicine Ltd. Major Depressive Disorder Drug Products Offered
12.8.5 Hua Medicine Ltd. Recent Development
12.9 Intra-Cellular Therapies, Inc.
12.9.1 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Corporation Information
12.9.2 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Business Overview and Total Revenue
12.9.3 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Products Offered
12.9.5 Intra-Cellular Therapies, Inc. Recent Development
13 Major Depressive Disorder Drug Manufacturing Cost Analysis
13.1 Major Depressive Disorder Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Major Depressive Disorder Drug
13.4 Major Depressive Disorder Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Major Depressive Disorder Drug Distributors List
14.3 Major Depressive Disorder Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Major Depressive Disorder Drug Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Major Depressive Disorder Drug Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Major Depressive Disorder Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Major Depressive Disorder Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Major Depressive Disorder Drug Sales Market Share by Region (2015-2020)
Table 6. Global Major Depressive Disorder Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Major Depressive Disorder Drug Revenue Share by Region (2015-2020)
Table 8. Global Major Depressive Disorder Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Major Depressive Disorder Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Major Depressive Disorder Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Major Depressive Disorder Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Major Depressive Disorder Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Major Depressive Disorder Drug Sales Share by Company (2015-2020)
Table 14. Global Major Depressive Disorder Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Major Depressive Disorder Drug Revenue Share by Company (2015-2020)
Table 16. Global Major Depressive Disorder Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Major Depressive Disorder Drug as of 2019)
Table 17. Global Major Depressive Disorder Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Major Depressive Disorder Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Major Depressive Disorder Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Major Depressive Disorder Drug Players
Table 22. Global Major Depressive Disorder Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Major Depressive Disorder Drug Sales Share by Type (2015-2020)
Table 24. Global Major Depressive Disorder Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Major Depressive Disorder Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Major Depressive Disorder Drug Sales Share by Type (2021-2026)
Table 27. Global Major Depressive Disorder Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Major Depressive Disorder Drug Revenue Share by Type (2021-2026)
Table 29. Global Major Depressive Disorder Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Major Depressive Disorder Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Major Depressive Disorder Drug Sales Share by Application (2015-2020)
Table 32. Global Major Depressive Disorder Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Major Depressive Disorder Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Major Depressive Disorder Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Major Depressive Disorder Drug Sales Share by Application (2021-2026)
Table 36. Global Major Depressive Disorder Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Major Depressive Disorder Drug Revenue Share by Application (2021-2026)
Table 38. Global Major Depressive Disorder Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Major Depressive Disorder Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Major Depressive Disorder Drug Sales Market Share by Company (2015-2020)
Table 41. United States Major Depressive Disorder Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
Table 43. United States Major Depressive Disorder Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Major Depressive Disorder Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Major Depressive Disorder Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Major Depressive Disorder Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Major Depressive Disorder Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Major Depressive Disorder Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
Table 51. China Major Depressive Disorder Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Major Depressive Disorder Drug Sales Market Share by Company (2015-2020)
Table 53. China Major Depressive Disorder Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
Table 55. China Major Depressive Disorder Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Major Depressive Disorder Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Major Depressive Disorder Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Major Depressive Disorder Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Major Depressive Disorder Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Major Depressive Disorder Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Major Depressive Disorder Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Major Depressive Disorder Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Major Depressive Disorder Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Major Depressive Disorder Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Major Depressive Disorder Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Major Depressive Disorder Drug Sales Market Share by Application (2015-2020)
Table 69. India Major Depressive Disorder Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Major Depressive Disorder Drug Sales Market Share by Company (2015-2020)
Table 71. India Major Depressive Disorder Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
Table 73. India Major Depressive Disorder Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Major Depressive Disorder Drug Sales Market Share by Application (2015-2020)
Table 75. Bristol-Myers Squibb Company Corporation Information
Table 76. Bristol-Myers Squibb Company Description and Business Overview
Table 77. Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Bristol-Myers Squibb Company Major Depressive Disorder Drug Product
Table 79. Bristol-Myers Squibb Company Recent Development
Table 80. Cerecor Inc. Corporation Information
Table 81. Cerecor Inc. Description and Business Overview
Table 82. Cerecor Inc. Major Depressive Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Cerecor Inc. Major Depressive Disorder Drug Product
Table 84. Cerecor Inc. Recent Development
Table 85. e-Therapeutics Plc Corporation Information
Table 86. e-Therapeutics Plc Description and Business Overview
Table 87. e-Therapeutics Plc Major Depressive Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. e-Therapeutics Plc Major Depressive Disorder Drug Product
Table 89. e-Therapeutics Plc Recent Development
Table 90. Eli Lilly and Company Corporation Information
Table 91. Eli Lilly and Company Description and Business Overview
Table 92. Eli Lilly and Company Major Depressive Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Eli Lilly and Company Major Depressive Disorder Drug Product
Table 94. Eli Lilly and Company Recent Development
Table 95. F. Hoffmann-La Roche Ltd. Corporation Information
Table 96. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 97. F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Product
Table 99. F. Hoffmann-La Roche Ltd. Recent Development
Table 100. GlaxoSmithKline Plc Corporation Information
Table 101. GlaxoSmithKline Plc Description and Business Overview
Table 102. GlaxoSmithKline Plc Major Depressive Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. GlaxoSmithKline Plc Major Depressive Disorder Drug Product
Table 104. GlaxoSmithKline Plc Recent Development
Table 105. H. Lundbeck A/S Corporation Information
Table 106. H. Lundbeck A/S Description and Business Overview
Table 107. H. Lundbeck A/S Major Depressive Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. H. Lundbeck A/S Major Depressive Disorder Drug Product
Table 109. H. Lundbeck A/S Recent Development
Table 110. Hua Medicine Ltd. Corporation Information
Table 111. Hua Medicine Ltd. Major Depressive Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Hua Medicine Ltd. Description and Business Overview
Table 113. Hua Medicine Ltd. Major Depressive Disorder Drug Product
Table 114. Hua Medicine Ltd. Recent Development
Table 115. Intra-Cellular Therapies, Inc. Corporation Information
Table 116. Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Intra-Cellular Therapies, Inc. Description and Business Overview
Table 118. Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Product
Table 119. Intra-Cellular Therapies, Inc. Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Major Depressive Disorder Drug Distributors List
Table 123. Major Depressive Disorder Drug Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Major Depressive Disorder Drug Product Picture
Figure 2. Global Major Depressive Disorder Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Major Depressive Disorder Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Research Center Examples
Figure 9. Global Major Depressive Disorder Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Major Depressive Disorder Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Major Depressive Disorder Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Major Depressive Disorder Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Major Depressive Disorder Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Major Depressive Disorder Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Major Depressive Disorder Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Major Depressive Disorder Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Major Depressive Disorder Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Major Depressive Disorder Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Major Depressive Disorder Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Major Depressive Disorder Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Major Depressive Disorder Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Major Depressive Disorder Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Major Depressive Disorder Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Major Depressive Disorder Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Major Depressive Disorder Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Major Depressive Disorder Drug Players Market Share by Revenue in Major Depressive Disorder Drug 2015 & 2019
Figure 27. Major Depressive Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Major Depressive Disorder Drug Revenue Share by Type (2015-2020)
Figure 29. Global Major Depressive Disorder Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Major Depressive Disorder Drug Revenue Share by Application (2015-2020)
Figure 31. Global Major Depressive Disorder Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Major Depressive Disorder Drug Sales Market Share by Type in 2019
Figure 33. United States Major Depressive Disorder Drug Sales Market Share by Type in 2019
Figure 34. Europe Major Depressive Disorder Drug Sales Market Share by Company in 2019
Figure 35. Europe Major Depressive Disorder Drug Sales Market Share by Type in 2019
Figure 36. Europe Major Depressive Disorder Drug Sales Market Share by Application in 2019
Figure 37. China Major Depressive Disorder Drug Sales Market Share by Company in 2019
Figure 38. China Major Depressive Disorder Drug Sales Market Share by Type in 2019
Figure 39. China Major Depressive Disorder Drug Sales Market Share by Application in 2019
Figure 40. Japan Major Depressive Disorder Drug Sales Market Share by Company in 2019
Figure 41. Japan Major Depressive Disorder Drug Sales Market Share by Type in 2019
Figure 42. Japan Major Depressive Disorder Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Major Depressive Disorder Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Major Depressive Disorder Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Major Depressive Disorder Drug Sales Market Share by Application in 2019
Figure 46. India Major Depressive Disorder Drug Sales Market Share by Company in 2019
Figure 47. India Major Depressive Disorder Drug Sales Market Share by Type in 2019
Figure 48. India Major Depressive Disorder Drug Sales Market Share by Application in 2019
Figure 49. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Cerecor Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. e-Therapeutics Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. H. Lundbeck A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Hua Medicine Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Intra-Cellular Therapies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Major Depressive Disorder Drug
Figure 60. Manufacturing Process Analysis of Major Depressive Disorder Drug
Figure 61. Major Depressive Disorder Drug Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
大鬱病性障害の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Major Depressive Disorder market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Major Depressive Di…- 大うつ病性障害治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Major Depressive Disorder Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Major D…
- 甲状腺ホルモン障害薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Thyroid Hormone Disorder Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Thyroid Hormone…
- 注意欠陥多動性障害（ADHD）薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Attention Deficit Hyperactivity Disorder (ADHD) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 20…
- 季節性情動障害治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Seasonal Affective Disorder Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Seasona…